---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-021567"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2025-11-10T23:59:59+00:00"
generated_at: "2026-05-16T22:21:47.550745+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma closes $1.0M private placement of Series C Preferred Stock to Hexstone Capital

## Summary
- Hexstone purchased 100 Series C Preferred shares at $10,000 each plus a warrant for up to 9,900 additional shares; total cash $1,000,099.
- Series C Preferred convertible into common at the lesser of $5.00 fixed price or 85% of lowest trading price over a specified period.
- Board authorized up to 9,900 shares of Series C Preferred via Certificate of Designation filed November 4, 2025.
- Securities issued under private placement exemption per Section 4(a)(2) and Regulation D.

## SEC filing metadata
- accession: 0001493152-25-021567
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2025-11-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315225021567/0001493152-25-021567-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315225021567/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-021567
- JSON: https://secwatch.observer/filing/0001493152-25-021567.json
- Plain text: https://secwatch.observer/filing/0001493152-25-021567.txt

## Key facts
- Governance Changes
  Propanc Biopharma, Inc.: Filed Certificate of Designation creating Series C Preferred Stock as an amendment to the Certificate of Incorporation (effective 2025-11-04).
  - Change: charter amendment
  - Effective: 2025-11-04
  source text: On November 4, 2025, the Company amended its Certificate of Incorporation and filed a Certificate of Designation with the Delaware Secretary of State that authorized the issuance of up to 9,900 shares of a new series of preferred stock, par value $0.01 per share, designated as “Series C Preferred Stock” for which the Board established the rights, preferences and limitations thereof.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1517681/000149315225021567/0001493152-25-021567-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.